Many Intrexon Corporation(XON) Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock. Intrexon Corp was Initiated by Northland Capital on Dec 29, 2016 to Outperform, Price Target of the shares are set at $40.
Company has reported several Insider transactions to the SEC, on Dec 14, 2016, Randal J Kirk (CEO) purchased 34,606 shares at 28.90 per share price.On Dec 13, 2016, Joel D Liffman (SVP, Finance) purchased 8,500 shares at 28.62 per share price.On Dec 5, 2016, Fred Hassan (director) purchased 6,900 shares at 29.02 per share price.
Intrexon Corp Last issued its quarterly earnings results on Nov 9, 2016. The company reported $-0.24 EPS for the quarter, missing the analyst consensus estimate by $ -0.07. Analyst had a consensus of $-0.17. The company had revenue of $48.99 million for the quarter, compared to analysts expectations of $51.70 million. The companys revenue was down -8.2 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $-0.34 EPS.
Intrexon Corporation (NYSE:XON) has received a short term rating of hold from experts at Zacks with a rank of 3. The stock has been rated an average of 1.67 by 6 Brokerage Firm. 4 Wall Street Firms have rated the stock as a strong buys. 2 Brokerage Firms have advised hold.
Intrexon Corporation (NYSE:XON): The mean short term price target for Intrexon Corporation (NYSE:XON) has been established at $42.25 per share. The higher price target estimate is at $57 and the lower price target estimate is expected at $29 according to 8 Analyst. The stock price is expected to vary based on the estimate which is suggested by the standard deviation value of $10.79
Intrexon Corporation (NYSE:XON) rose 4.58% or 1.02 points on Tuesday and made its way into the gainers of the day. After trading began at $22.25 the stock was seen hitting $23.3401 as a peak level and $22.13 as the lowest level. The stock ended up at $23.29. The daily volume was measured at 1,351,937 shares. The 52-week high of the share price is $39.854171 and the 52-week low is $20.39. The company has a market cap of $2,762 million.
Intrexon Corporation is a biotechnology company. It provides synthetic biology services. The Company designs and produces modular DNA control systems and applications for human therapeutics, protein production, industrial products, agricultural biotechnology, and animal sciences. Its technologies include the UltraVector gene design and fabrication platform; Cell Systems Informatics; LEAP-cell identification and selection, and mAbLogix-antibody discovery. Intrexon Corporation is based in Germantown, Maryland.